This review of the side effects of medications prescribed for the management of mental health highlights their potential impact on oral health. The commonest problems being xerostomia.
[read the full story...]Should people with schizophrenia be offered depot antipsychotics as first line treatment?
Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.
[read the full story...]Psychotropic medication: finding ways forward for adults with intellectual disabilities #RSMpsychotropics
Rory Sheehan and Angela Hassiotis discuss how to optimise psychotropic medication for people with intellectual disabilities; the theme of their #RSMpsychotropics conference taking place in London today.
[read the full story...]Antidepressants for bipolar depression: weighing up the benefits and harms
Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.
[read the full story...]Antipsychotics for delirium in palliative care: new RCT suggests non-drug alternatives are needed
Samei Huda highlights a recent RCT of antipsychotics (risperidone and haloperidol) versus placebo for symptoms of delirium in palliative care, which suggests we need non-drug alternatives for this group of patients.
[read the full story...]Risperidone versus placebo for people with schizophrenia
Joanne Wallace summarises the recent Cochrane systematic review on risperidone versus placebo for schizophrenia, which concludes that the best available evidence does not show that the benefits of risperidone outweigh the harms.
[read the full story...]Antipsychotic efficacy measured by real-world observational study
Tracey Roberts examines whether a retrospective observational study accurately investigates the effectiveness of second and first generation antipsychotics.
[read the full story...]Depot antipsychotics: If you pay me, you can keep injecting me
John Baker looks at the 2-year follow-up results of a cluster RCT on the effectiveness of financial incentives to improve adherence to maintenance treatment with depot antipsychotics.
[read the full story...]Bipolar disorder in older men linked to increased risk of dementia
Elena Marcus presents a recent study that shows how older Australian men with bipolar disorder have an increased risk of dementia and early death.
[read the full story...]The side-effects of antipsychotics: let’s systematically assess, discuss and act! #NPNR2016
A live blog published at the 22nd International Network for Psychiatric Nursing Research conference in Nottingham.
Written by John Baker, Lucy Brazener, Wendy Cross, Vanessa Garrity, Andrew Grundy, Cher Hallett, Ben Hannigan, Elaine Hanzak and Alan Simpson.
[read the full story...]